title: Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells.
abstract: D2L dopamine receptor activation results in rapid inhibition and delayed heterologous sensitization of adenylate cyclase in several host cell types. The D2L dopamine receptor was stably transfected into NS20Y neuroblastoma cells to examine inhibition and sensitization in a neuronal cell environment and to identify the particular G-proteins involved. Acute activation of D2L receptors with the selective D2 agonist quinpirole inhibited forskolin-stimulated cAMP accumulation, whereas prolonged incubation (2 hr) with quinpirole resulted in heterologous sensitization (more than twofold) of forskolin-stimulated cAMP accumulation in NS20Y-D2L cells. To unambiguously identify the pertussis toxin (PTX)-sensitive G-proteins responsible for inhibition and sensitization, we used viral-mediated gene delivery to assess the ability of genetically engineered PTX-resistant G-proteins (Galphai1*, Galphai2*, Galphai3*, and Galphao*) to rescue both responses after PTX treatment. The expression and function of individual recombinant G-proteins was confirmed with Western blotting and inhibition of GTPgammaS-stimulated adenylate cyclase, respectively. To assess the specificity of D2L-Galpha coupling, cells were infected with herpes simplex virus (HSV) recombinants expressing individual PTX-resistant G-protein alpha subunits and treated with PTX, and quinpirole-induced responses were measured. Infection of NS20Y-D2L cells with HSV-Galphao* rescued both inhibition and sensitization in PTX-treated cells, whereas infection with HSV-Galphai1*, HSV-Galphai2*, or HSV-Galphai3* failed to rescue either response. In summary, the current study provides strong evidence that the D2L dopamine receptor couples to Galphao in neuronal cells, and that this coupling is responsible for both the acute and subacute effects of D2 receptor activation on adenylate cyclase activity.
authors.affiliation: Medical Research Service, Veterans Affairs Medical Center, and Department of Behavioral Neuroscience, Oregon Health Sciences University, Portland, Oregon 97201, USA.
authors.forename: V J
authors.initials: VJ
authors.lastname: Watts
authors.forename: B L
authors.initials: BL
authors.lastname: Wiens
authors.forename: M G
authors.initials: MG
authors.lastname: Cumbay
authors.forename: M N
authors.initials: MN
authors.lastname: Vu
authors.forename: R L
authors.initials: RL
authors.lastname: Neve
authors.forename: K A
authors.initials: KA
authors.lastname: Neve
mesh_terms: D037361:Adenylate Cyclase Toxin; D000818:Animals; D005576:Colforsin / Q000494:pharmacology; D000242:Cyclic AMP / Q000378:metabolism; D004789:Enzyme Activation; D019204:GTP-Binding Proteins / Q000378:metabolism / Q000502:physiology*; D005822:Genetic Vectors; D051379:Mice; D009447:Neuroblastoma; D009474:Neurons / Q000502:physiology*; D037342:Pertussis Toxin; D019257:Quinpirole / Q000494:pharmacology; D017448:Receptors, Dopamine D2 / Q000737:chemistry / Q000235:genetics / Q000502:physiology*; D018139:Simplexvirus / Q000235:genetics; D014162:Transfection; D014407:Tumor Cells, Cultured; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
chemical_list: D037361:Adenylate Cyclase Toxin; D017448:Receptors, Dopamine D2; D010566:Virulence Factors, Bordetella; C113776:dopamine D2L receptor; D005576:Colforsin; D019257:Quinpirole; D000242:Cyclic AMP; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins